AMA Launches Vaccine Review Initiative Amid CDC Changes

The American Medical Association (AMA) has announced a new initiative to establish an independent system for reviewing vaccine safety and effectiveness. This move comes in response to significant changes within the Centers for Disease Control and Prevention (CDC), which many experts claim have undermined public confidence in the agency’s vaccine recommendations. The AMA is partnering with the Vaccine Integrity Project from the University of Minnesota to conduct evidence reviews focusing initially on vaccines for influenza, COVID-19, and respiratory syncytial virus (RSV).

The initiative is deemed necessary as the CDC’s vaccine review process has been described as having “effectively collapsed.” The groups involved will not issue vaccine recommendations but will provide their findings to state health officials, clinicians, and other stakeholders involved in vaccination decisions. This collaborative effort aims to ensure a rigorous, evidence-based approach to vaccine policy.

In a joint statement released on September 26, 2023, the AMA and the Vaccine Integrity Project emphasized their commitment to a transparent evaluation process. They plan to convene various medical professional societies, public health organizations, and healthcare entities to replicate the thorough and deliberative standards historically maintained by the CDC.

The involvement of the AMA is particularly noteworthy, as the organization has primarily concentrated on issues like physician reimbursement and medical billing, rather than public health evidence reviews. The decision to create a parallel vaccine review process reflects the serious concerns among medical leaders regarding the current state of vaccine oversight under the administration of Health Secretary Robert F. Kennedy Jr..

Jeanne Marrazzo, Chief Executive of the Infectious Diseases Society of America and former director of the National Institute of Allergy and Infectious Diseases, commented on the AMA’s new role, stating, “This signals an important foray for them into this space,” highlighting the growing worry around evidence-based recommendations.

For decades, the CDC’s Advisory Committee on Immunization Practices (ACIP) has set the standards for vaccine recommendations in the United States. Although these recommendations were advisory, they were widely adopted by healthcare providers, school systems, and insurers. However, the recent firing of all 17 members of the ACIP by Kennedy, coupled with the appointment of a new panel that includes vaccine skeptics, has raised alarms within the public health community.

In December 2022, the ACIP made a controversial decision to drop the longstanding recommendation for newborns to receive the hepatitis B vaccine, a move criticized by numerous medical experts. Andrew Nixon, a spokesperson for the Department of Health and Human Services (HHS), dismissed claims regarding the collapse of ACIP’s evidence-based process, maintaining that the committee remains the nation’s advisory body for vaccine recommendations driven by rigorous scientific standards.

The new initiative by the AMA and the Vaccine Integrity Project responds to concerns raised by leading public health experts. The acting director of the CDC recently took the unprecedented step of reducing the number of vaccines routinely recommended for children, a decision criticized for bypassing expert input. Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, described the new AMA initiative as an essential attempt to fill “a huge black hole in public health and medical practice.”

Sandra Adamson Fryhofer, an AMA trustee and liaison to the CDC vaccine panel, emphasized the responsibility of healthcare professionals to ensure a transparent, evidence-based approach for vaccine recommendations. She stated, “Together, we are committed to ensuring the American public has clear, evidence-based guidance that inspires confidence when making important vaccination decisions.”

The Vaccine Integrity Project has previously published evidence reviews and convened panels examining scientific studies on vaccines for COVID-19, influenza, and RSV. The addition of the AMA’s efforts highlights a pressing need for clarity and trust in vaccination policies during a critical time for public health.